OTCMKTS:SVON

(SVON) (SVON) Stock Price, News & Analysis

Notice: This company has been marked as potentially delisted and may not be actively trading.
Today's Range
$0.29
$0.37
50-Day Range
N/A
52-Week Range
$0.13
$0.44
Volume
533,681 shs
Average Volume
97,866 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
SVON stock logo

About (SVON) Stock (OTCMKTS:SVON)

Eloxx Pharmaceuticals, Inc. engages in the development of novel ribonucleic acid-modulating drug candidates. The firm focuses on the the formulation of medicines to treat rare and ultra-rare premature stop codon diseases. Its lead product candidate is ELX-02, a small molecule drug designed to restore production of full-length functional proteins. It operates through the United States and Israel geographical segments. The company was founded by Silvia Noiman on December 19, 2017 and is headquartered in Waltham, MA.

SVON Stock News Headlines

See More Headlines
Receive SVON Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for (SVON) and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
5/22/2017
Today
5/16/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Biotechnology
Sub-Industry
N/A
Current Symbol
OTCMKTS:SVON
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
The 10 Best AI Stocks to Own in 2024 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

Key Executives

  • Sumit Aggarwal
    President, Chief Executive Officer & Director
  • Neil S. Belloff
    COO, Secretary, EVP & General Counsel
  • Daniel E. Geffken
    Chief Financial Officer
  • Thomas P. Haverty
    Chief Medical Officer
  • Vijay Modur
    Head-Research & Development

SVON Stock Analysis - Frequently Asked Questions

How were (SVON)'s earnings last quarter?

(SVON) (OTCMKTS:SVON) issued its earnings results on Monday, May, 22nd. The company reported ($0.09) earnings per share for the quarter.

What other stocks do shareholders of (SVON) own?

Based on aggregate information from My MarketBeat watchlists, some companies that other (SVON) investors own include Canopy Growth (WEED), Pulse Biosciences (PLSE), Inovio Pharmaceuticals (INO), Galectin Therapeutics (GALT), EMC (EMC), Check-Cap (CHEK) and Anavex Life Sciences (AVXL).

This page (OTCMKTS:SVON) was last updated on 5/17/2024 by MarketBeat.com Staff

From Our Partners